Discover effective solutions for dry skin, eczema, acne scars, and psoriasis in this step-by-step skincare routine with ...

Johnson & Johnson's much-anticipated oral IL-23 inhibitor, icotrokinra, has claimed FDA approval as a first-line treatment for plaque psoriasis. The US regulator has approved icotrokinra under the ...

Moving house or going through a break-up - and pimples suddenly appear or your eczema flare up? E fit no be coincidence.

The emotional burden of psoriasis can be as significant as the physical symptoms. Learn how to manage the shame and stigma you may feel through effective medical treatments, self-care, peer support, ...

Phase 3 studies showed zasocitinib, a highly selective oral tyrosine kinase 2 inhibitor, provided rapid, durable skin improvement.

Acne is a common and clinically relevant adverse event among patients with IBD receiving JAK inhibitors. Acne occurs in 8.6% of individuals with inflammatory bowel diseases (IBD) who are receiving ...

Folks with severe plaque psoriasis often have to choose between convenient pills that don't work very well or highly ...

Melinda Gooderham, MD, MSc, FRCPC, discusses findings from the Latitude PsO 3001 and Latitude PsO 3002 studies evaluating zasocitinib. This content was developed independently and is not endorsed by ...

Data presentations underscore category leadership and expertise in dermatology and immunology MUMBAI, India and PRINCETON, N.J., March 27, 2026 /PRNewswire/ -- Sun Pharmaceutical Industries Limited ...